Selnoflast (development codes RO7486967, RG-6418, IZD334) is an experimental small-molecule drug developed by Hoffmann-La Roche for the treatment of neuroinflammatory conditions.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.